BCR-ABL1 is a secondary event after JAK2V617F in patients with polycythemia vera who develop chronic myeloid leukemia
Publication/Presentation Date
2-2013
Volume
121
Issue
7
First Page
1238
Last Page
1239
Published In/Presented At
Xiaoli Wang, Joseph Tripodi, Marina Kremyanskaya, Amanda Blouin, Paul Roda, Ronald Hoffman, Vesna Najfeld; BCR-ABL1 is a secondary event after JAK2V617F in patients with polycythemia vera who develop chronic myeloid leukemia. Blood 2013; 121 (7): 1238–1239. doi: https://doi.org/10.1182/blood-2012-11-467787
Disciplines
Medicine and Health Sciences
Department(s)
Department of Medicine
Document Type
Article
COinS